Stroke, myocardial infarction, or vascular death · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates probably leads to lower composite outcome of non‐fatal stroke, non‐fatal myocardial… compared with control (moderate certainty).
1 finding from 1 review
Fatal or nonfatal stroke · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in stroke (ischaemic or haemorrhagic, non‐fatal or fatal) during the… compared with control (low certainty).
2 findings from 1 review
Death from any cause during the treatment and scheduled · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in death from any cause during the treatment and scheduled compared with control (low certainty).
2 findings from 1 review
Deaths due to vascular events · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in death from vascular causes during the treatment and scheduled compared with control (low certainty).
2 findings from 1 review
Fatal or nonfatal myocardial infarction · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates probably leads to lower myocardial infarction (non‐fatal or fatal) during the treatment and… compared with control (moderate certainty).
2 findings from 1 review
Composite outcome of non‐fatal stroke, non‐fatal myocardial infarction, and vascular death without clofibrate · People with previous clinical manifestations of cardiovascular disease, transient ischaemic attack, or stroke
Fibrates showed no clear difference in composite outcome of non‐fatal stroke, non‐fatal myocardial… compared with control (low certainty).
1 finding from 1 review
Intervention not reported
Combined CVD death, non‐fatal MI, or non‐fatal stroke · patients in primary prevention of cardiovascular disease events
The intervention probably leads to lower combined CVD death, non‐fatal MI, or non‐fatal stroke (moderate certainty).
1 finding from 1 review
Intervention not reported
Combined coronary heart disease death or non‐fatal MI · patients in primary prevention of cardiovascular disease events
The intervention probably leads to lower combined coronary heart disease death or non‐fatal MI (moderate certainty).
1 finding from 1 review
Intervention not reported
Overall mortality · patients in primary prevention of cardiovascular disease events
The intervention showed no clear difference in overall mortality (low certainty).
1 finding from 1 review
Intervention not reported
Non‐CVD mortality · patients in primary prevention of cardiovascular disease events
The intervention showed no clear difference in non‐CVD mortality (low certainty).
1 finding from 1 review
Intervention not reported
Discontinuation of therapy due to adverse effects · patients in primary prevention of cardiovascular disease events
It is very uncertain whether the intervention changes discontinuation of therapy due to adverse effects (very low certainty).
1 finding from 1 review